PMC:7396557 / 92198-92400 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T994","span":{"begin":94,"end":108},"obj":"CHEBI:15627;CHEBI:15627"},{"id":"T995","span":{"begin":110,"end":114},"obj":"CHEBI:9750;CHEBI:9750"},{"id":"T996","span":{"begin":119,"end":124},"obj":"UBERON:0000178"},{"id":"T75174","span":{"begin":94,"end":108},"obj":"CHEBI:15627;CHEBI:15627"},{"id":"T60887","span":{"begin":110,"end":114},"obj":"CHEBI:9750;CHEBI:9750"},{"id":"T21493","span":{"begin":119,"end":124},"obj":"UBERON:0000178"}],"text":"After treatment, patients in the SMI treatment group had increased prostacyclin PGI2 and PGI2/thromboxane A2 (TXA2) in blood to a certain extent compared to patients in the conventional treatment group."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T517","span":{"begin":106,"end":108},"obj":"Body_part"},{"id":"T518","span":{"begin":119,"end":124},"obj":"Body_part"}],"attributes":[{"id":"A517","pred":"fma_id","subj":"T517","obj":"http://purl.org/sig/ont/fma/fma66595"},{"id":"A518","pred":"fma_id","subj":"T518","obj":"http://purl.org/sig/ont/fma/fma9670"}],"text":"After treatment, patients in the SMI treatment group had increased prostacyclin PGI2 and PGI2/thromboxane A2 (TXA2) in blood to a certain extent compared to patients in the conventional treatment group."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T270","span":{"begin":119,"end":124},"obj":"Body_part"}],"attributes":[{"id":"A270","pred":"uberon_id","subj":"T270","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"After treatment, patients in the SMI treatment group had increased prostacyclin PGI2 and PGI2/thromboxane A2 (TXA2) in blood to a certain extent compared to patients in the conventional treatment group."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T875","span":{"begin":106,"end":108},"obj":"http://purl.obolibrary.org/obo/CLO_0001562"},{"id":"T876","span":{"begin":119,"end":124},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T877","span":{"begin":119,"end":124},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T878","span":{"begin":128,"end":129},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"After treatment, patients in the SMI treatment group had increased prostacyclin PGI2 and PGI2/thromboxane A2 (TXA2) in blood to a certain extent compared to patients in the conventional treatment group."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T83943","span":{"begin":47,"end":52},"obj":"Chemical"},{"id":"T14904","span":{"begin":80,"end":84},"obj":"Chemical"},{"id":"T19414","span":{"begin":89,"end":93},"obj":"Chemical"},{"id":"T1042","span":{"begin":94,"end":108},"obj":"Chemical"},{"id":"T43391","span":{"begin":94,"end":105},"obj":"Chemical"},{"id":"T3785","span":{"begin":110,"end":114},"obj":"Chemical"},{"id":"T90792","span":{"begin":196,"end":201},"obj":"Chemical"}],"attributes":[{"id":"A48119","pred":"chebi_id","subj":"T83943","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A3575","pred":"chebi_id","subj":"T14904","obj":"http://purl.obolibrary.org/obo/CHEBI_15552"},{"id":"A68116","pred":"chebi_id","subj":"T19414","obj":"http://purl.obolibrary.org/obo/CHEBI_15552"},{"id":"A5293","pred":"chebi_id","subj":"T1042","obj":"http://purl.obolibrary.org/obo/CHEBI_15627"},{"id":"A83342","pred":"chebi_id","subj":"T1042","obj":"http://purl.obolibrary.org/obo/CHEBI_57445"},{"id":"A35739","pred":"chebi_id","subj":"T43391","obj":"http://purl.obolibrary.org/obo/CHEBI_26995"},{"id":"A79658","pred":"chebi_id","subj":"T3785","obj":"http://purl.obolibrary.org/obo/CHEBI_15627"},{"id":"A84301","pred":"chebi_id","subj":"T90792","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"After treatment, patients in the SMI treatment group had increased prostacyclin PGI2 and PGI2/thromboxane A2 (TXA2) in blood to a certain extent compared to patients in the conventional treatment group."}

{"project":"LitCovid-sentences","denotations":[{"id":"T690","span":{"begin":0,"end":202},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"After treatment, patients in the SMI treatment group had increased prostacyclin PGI2 and PGI2/thromboxane A2 (TXA2) in blood to a certain extent compared to patients in the conventional treatment group."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2632","span":{"begin":17,"end":25},"obj":"Species"},{"id":"2633","span":{"begin":157,"end":165},"obj":"Species"},{"id":"2637","span":{"begin":67,"end":79},"obj":"Chemical"},{"id":"2638","span":{"begin":80,"end":84},"obj":"Chemical"},{"id":"2639","span":{"begin":89,"end":93},"obj":"Chemical"},{"id":"2640","span":{"begin":94,"end":108},"obj":"Chemical"},{"id":"2641","span":{"begin":110,"end":114},"obj":"Chemical"}],"attributes":[{"id":"A2632","pred":"tao:has_database_id","subj":"2632","obj":"Tax:9606"},{"id":"A2633","pred":"tao:has_database_id","subj":"2633","obj":"Tax:9606"},{"id":"A2637","pred":"tao:has_database_id","subj":"2637","obj":"MESH:D011464"},{"id":"A2638","pred":"tao:has_database_id","subj":"2638","obj":"MESH:D011464"},{"id":"A2639","pred":"tao:has_database_id","subj":"2639","obj":"MESH:D011464"},{"id":"A2640","pred":"tao:has_database_id","subj":"2640","obj":"MESH:D013928"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"After treatment, patients in the SMI treatment group had increased prostacyclin PGI2 and PGI2/thromboxane A2 (TXA2) in blood to a certain extent compared to patients in the conventional treatment group."}